Journey Medical Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

SUBSEQUENT EVENTS (Details)

v3.22.1

SUBSEQUENT EVENTS (Details) - Subsequent Event - USD ($) $ in Millions	Feb. 11, 2022	Jan. 13, 2022	Jan. 12, 2022
East West Bank \| Third Amendment [Member] \| Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 10.0
Current borrowing capacity			$ 7.5
East West Bank \| Third Amendment [Member] \| Revolving Credit Facility [Member] \| Prime Rate
Subsequent Event [Line Items]
Spread on variable rate			0.70%
East West Bank \| Third Amendment [Member] \| Term Loan
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 20.0
Current borrowing capacity			15.0
Remaining borrowing capacity			$ 5.0
East West Bank \| Third Amendment [Member] \| Term Loan \| Prime Rate
Subsequent Event [Line Items]
Spread on variable rate			1.73%
VYNE Therapeutics Product Acquisition Agreement [Member] \| East West Bank \| Third Amendment [Member] \| Term Loan
Subsequent Event [Line Items]
Current borrowing capacity			$ 15.0
VYNE Therapeutics Product Acquisition Agreement [Member] \| Molecule Stabilizing Technology [Member]
Subsequent Event [Line Items]
Upfront fees		$ 20.0
Milestone payments payable		$ 5.0
Asset Purchase Agreement With Dermira Inc [Member]
Subsequent Event [Line Items]
Milestone payment, offset amount	$ 7.5
Licensing Agreement With Maruho [Member]
Subsequent Event [Line Items]
Milestone payment due, period	30 days
Licensing Agreement With Maruho [Member] \| Qbrexza [Member]
Subsequent Event [Line Items]
Milestone payment received, gross	$ 10.0
Milestone payment received, net	$ 2.5

- Definition

Amount of milestone payments to be paid in asset purchase agreement.

+ References

No definition available.

+ Details

Name:	derm_AssetPurchaseAgreementMilestonePaymentsPayable
Namespace Prefix:	derm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of upfront fees paid in asset purchase agreement.

+ References

No definition available.

+ Details

Name:	derm_AssetPurchaseAgreementUpfrontFees
Namespace Prefix:	derm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The due period for milestone payment.

+ References

No definition available.

+ Details

Name:	derm_MilestonePaymentDuePeriod
Namespace Prefix:	derm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of milestone payment, offset.

+ References

No definition available.

+ Details

Name:	derm_MilestonePaymentOffsetAmount
Namespace Prefix:	derm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of milestone payment received.

+ References

No definition available.

+ Details

Name:	derm_MilestonePaymentReceivedGross
Namespace Prefix:	derm_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of milestone payment received, net.

+ References

No definition available.

+ Details

Name:	derm_MilestonePaymentReceivedNet
Namespace Prefix:	derm_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage points added to the reference rate to compute the variable rate on the debt instrument.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.

+ References

+ Details

Name:	us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).

+ References

+ Details

Name:	us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LineOfCreditFacilityAxis=derm_EastWestBankMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=derm_ThirdAmendmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VariableRateAxis=us-gaap_PrimeRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CreditFacilityAxis=derm_TermLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=derm_VyneTherapeuticsProductAcquisitionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=derm_MoleculeStabilizingTechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=derm_AssetPurchaseAgreementWithDermiraIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=derm_LicensingAgreementWithMaruhoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=derm_QbrexzaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: